We are live on ! Find out more
PM

Penbrook Management Portfolio holdings

AUM $132M
1-Year Est. Return 29.91%
This Fund
S&P 500
This Quarter Est. Return
-1.08%
1 Year Est. Return
+29.91%
3 Year Est. Return
+77.31%
5 Year Est. Return
+126.31%
10 Year Est. Return
AUM
$132M
AUM Growth
-$12.9M
Cap. Flow
-$6.05M
Cap. Flow %
-4.58%
Top 10 Hldgs %
47.13%
Holding
105
New
8
Increased
14
Reduced
28
Closed
12

Top Buys

Rank Stock Value
1
PRTA icon
Prothena Corp
PRTA
+$2.49M
2
EXTR icon
Extreme Networks
EXTR
+$1.25M
3
CYRX icon
CryoPort
CYRX
+$1.2M
4
CURI icon
CuriosityStream
CURI
+$1.11M
5
MGNI icon
Magnite
MGNI
+$1.09M

Top Sells

Rank Stock Value
1
PL icon
Planet Labs
PL
+$4.84M
2
SYF icon
Synchrony
SYF
+$1.29M
3
AEHR icon
Aehr Test Systems
AEHR
+$1.13M
4
COHU icon
Cohu
COHU
+$891K
5
BPOP icon
Popular Inc
BPOP
+$851K

Sector Composition

Rank Sector Weight
1 Technology 23.13%
2 Healthcare 16.73%
3 Communication Services 15.08%
4 Energy 11.67%
5 Consumer Discretionary 9.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EMR icon
51
Emerson Electric
EMR
$78.2B
$694K 0.53%
5,300
WES icon
52
Western Midstream Partners
WES
$19B
$655K 0.5%
15,900
RRC icon
53
Range Resources
RRC
$8.66B
$643K 0.49%
14,240
REGN icon
54
Regeneron Pharmaceuticals
REGN
$70.9B
$607K 0.46%
785
-12
-2% -$9.19K
QQQ icon
55
Invesco QQQ Trust
QQQ
$462B
$534K 0.4%
925
-945
-51% -$574K
LINC icon
56
Lincoln Educational Services
LINC
$1.36B
$518K 0.39%
12,740
-4,286
-25% -$135K
FBP icon
57
First Bancorp
FBP
$4.24B
$502K 0.38%
23,500
-21,400
-48% -$461K
PIM
58
Franklin Master Intermediate Income Trust
PIM
$152M
$481K 0.36%
147,063
PAR icon
59
PAR Technology
PAR
$674M
$477K 0.36%
35,775
+15,960
+81% +$375K
POWI icon
60
Power Integrations
POWI
$3.93B
$471K 0.36%
9,200
KLIC icon
61
Kulicke & Soffa
KLIC
$5.09B
$467K 0.35%
7,100
BLFS icon
62
BioLife Solutions
BLFS
$1.42B
$442K 0.33%
23,155
+200
+0.9% +$4.42K
DMLP icon
63
Dorchester Minerals
DMLP
$1.31B
$440K 0.33%
16,225
EPD icon
64
Enterprise Products Partners
EPD
$82.6B
$432K 0.33%
11,427
FNF icon
65
Fidelity National Financial
FNF
$14B
$425K 0.32%
9,168
-11,153
-55% -$579K
AAPL icon
66
Apple
AAPL
$4.9T
$388K 0.29%
1,529
BMY icon
67
Bristol-Myers Squibb
BMY
$124B
$379K 0.29%
6,250
OSS icon
68
One Stop Systems
OSS
$313M
$354K 0.27%
46,740
PAYS icon
69
Paysign
PAYS
$478M
$329K 0.25%
55,785
+24,960
+81% +$101K
RSP icon
70
Invesco S&P 500 Equal Weight ETF
RSP
$96B
$321K 0.24%
1,670
IBM icon
71
IBM
IBM
$200B
$311K 0.24%
1,283
-344
-21% -$93.1K
CVX icon
72
Chevron
CVX
$373B
$285K 0.22%
1,377
COP icon
73
ConocoPhillips
COP
$140B
$267K 0.2%
+2,025
New +$224K
KOPN icon
74
Kopin
KOPN
$706M
$258K 0.2%
114,575
-400
-0.3% -$968
BLZE icon
75
Backblaze
BLZE
$793M
$249K 0.19%
72,150
+800
+1% +$3.37K

Similar funds

Penbrook Management's Q1 2026 Portfolio in Review

As of Q1 2026, Penbrook Management held 105 positions worth $132M, down 8.9% from $145M the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Penbrook Management withdrew a net $6.05M in Q1 2026, closing 12 positions and reducing 28 holdings. Its most notable exit was Synchrony, an estimated $1.29M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Communication Services.

Against the trend, Penbrook Management opened a new position in Prothena Corp worth $2.64M.

  • Penbrook Management's largest Q1 2026 buy was Prothena Corp: 271,720 shares worth $2.64M.
  • Penbrook Management added most to CryoPort in Q1 2026, an estimated $1.2M increase.
  • Penbrook Management's biggest Q1 2026 reduction was Planet Labs, cutting an estimated $4.84M.
  • Penbrook Management fully exited Synchrony in Q1 2026, selling an estimated $1.29M.
  • Penbrook Management's ten largest holdings make up 47% of its $132M portfolio in Q1 2026.
  • Penbrook Management opened 8 new positions and closed 12 in Q1 2026.
  • Penbrook Management's portfolio value fell 8.9% quarter-over-quarter to $132M.

Based on Penbrook Management's 13F filing for Q1 2026, filed 21 Apr 2026.